These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14989403)

  • 1. Overview of the First Annual Workshop on the Schizophrenia Prodrome.
    Auther AM; Lencz T; Smith CW; Bowie CR; Cornblatt BA
    Schizophr Bull; 2003; 29(4):625-31. PubMed ID: 14989403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary: Progress, issues, and implications of prodromal research: an inside view.
    McGlashan TH
    Schizophr Bull; 2003; 29(4):851-8. PubMed ID: 14989419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conceptual and methodological advances in prodromal research. Proceedings of the First Annual Workshop of the Schizophrenia Prodrome. April 4-6, 2002. New York, New York, USA.
    Schizophr Bull; 2003; 29(4):621-879. PubMed ID: 15307226
    [No Abstract]   [Full Text] [Related]  

  • 4. Toward a better identification and treatment of schizophrenia prodrome.
    Bota RG; Sagduyu K; Filin EE; Bota DA; Munro S
    Bull Menninger Clin; 2008; 72(3):210-27. PubMed ID: 18990056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of pharmacotherapy in the prodrome of schizophrenia.
    Remington G; Shammi C
    CNS Spectr; 2004 Aug; 9(8):579-86. PubMed ID: 15273650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The schizophrenia prodrome revisited: a neurodevelopmental perspective.
    Cornblatt BA; Lencz T; Smith CW; Correll CU; Auther AM; Nakayama E
    Schizophr Bull; 2003; 29(4):633-51. PubMed ID: 14989404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition to schizophrenia and related disorders: toward a taxonomy of risk.
    Maier W; Cornblatt BA; Merikangas KR
    Schizophr Bull; 2003; 29(4):693-701. PubMed ID: 14989407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming barriers to research in early serious mental illness: issues for future collaboration.
    Heinssen RK; Cuthbert BN; Breiling J; Colpe LJ; Dolan-Sewell R
    Schizophr Bull; 2003; 29(4):737-45. PubMed ID: 14989411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of the schizophrenia prodrome: is it presently ethical?
    Cornblatt BA; Lencz T; Kane JM
    Schizophr Res; 2001 Aug; 51(1):31-8. PubMed ID: 11479063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed Consent in Early Psychosis Research: National Institute of Mental Health workshop, November 15, 2000.
    Heinssen RK; Perkins DO; Appelbaum PS; Fenton WS
    Schizophr Bull; 2001; 27(4):571-83. PubMed ID: 11824484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: Chickens and eggs; carts and horses: an outsider's perspective on the study of the early stages and potential prevention of psychosis and schizophrenia.
    Harvey PD
    Schizophr Bull; 2003; 29(4):845-9. PubMed ID: 14989418
    [No Abstract]   [Full Text] [Related]  

  • 12. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.
    Miller TJ; McGlashan TH; Rosen JL; Cadenhead K; Cannon T; Ventura J; McFarlane W; Perkins DO; Pearlson GD; Woods SW
    Schizophr Bull; 2003; 29(4):703-15. PubMed ID: 14989408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment models and designs for intervention research during the psychotic prodrome.
    Kane JM; Krystal J; Correll CU
    Schizophr Bull; 2003; 29(4):747-56. PubMed ID: 14989412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase.
    Weiser M
    Am J Psychiatry; 2011 Aug; 168(8):761-3. PubMed ID: 21813489
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethics of the early intervention in the treatment of schizophrenia.
    Filaković P; Degmecić D; Koić E; Benić D
    Psychiatr Danub; 2007 Sep; 19(3):209-15. PubMed ID: 17914322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental precursors and biological markers for schizophrenia and affective disorders: specificity and public health implications.
    Jones PB; Tarrant CJ
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(6):286-91. PubMed ID: 11153963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dilemma of early drug intervention in prepsychotic illnesses of adolescence].
    Branik E; Meng H
    Prax Kinderpsychol Kinderpsychiatr; 2003 Dec; 52(10):751-65. PubMed ID: 14699785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.
    Nasrallah HA; Keshavan MS; Benes FM; Braff DL; Green AI; Gur RE; Kane JM; Perkins DO; Weiden PJ; Weinberger DR; Correll CU
    J Clin Psychiatry; 2009; 70 Suppl 1():4-46. PubMed ID: 19292973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
    Lecardeur L; Meunier-Cussac S; Dollfus S
    Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
    Correll CU; Smith CW; Auther AM; McLaughlin D; Shah M; Foley C; Olsen R; Lencz T; Kane JM; Cornblatt BA
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):475-90. PubMed ID: 18928412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.